Need professional-grade analysis? Visit stockanalysis.com
$2.59B
11.27
2,243
2.45%
Nippon Shinyaku Co Ltd ADR (NPPNY) trades on United States in USD. The company is classified in the Healthcare sector under the Drug Manufacturers - Specialty & Generic industry. The stock currently trades at $8.15.
Over the past year, NPPNY has traded between a low of $5.03 and a high of $15.21. The stock has gained 31.6% over this period. It is currently 46.4% below its 52-week high.
Nippon Shinyaku Co Ltd ADR has a market capitalization of $2.59B, with a price-to-earnings ratio of 11.27 and a dividend yield of 2.45%.
Nippon Shinyaku Co., Ltd. manufactures and sells pharmaceuticals and foodstuffs in Japan and internationally. The company operates through Pharmaceuticals and Functional Food Business segments. It offers drugs in the fields of urology, hematology, intractable and rare diseases, gynecology, and other diseases; health food ingredients, preservatives, protein preparations, and supplements. The company in the Strategic Partnership with Nippon Shinyaku to develop ATSN-10 that is in Phase I/II of clinical trials for the treatment of GUCY2D-mutant Leber congenital amaurosis; and RGX-121 for the treatment of mucopolysaccharidosis. Nippon Shinyaku Co., Ltd. was founded in 1911 and is headquartered in Kyoto, Japan.
Side-by-side comparison against top Healthcare peers.